| RS770324764 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Ullrich congenital muscular dystrophy 2 |
| RS770324989 |
TNFRSF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
TNF receptor-associated periodic fever syndrome (TRAPS), Autoinflammatory syndrome |
| RS770325118 |
UNC13D
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome, Familial hemophagocytic lymphohistiocytosis 3 |
| RS770325540 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS770326964 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS770327474 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Ovarian cancer |
| RS770328302 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS770328474 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS770329105 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS770329421 |
DLL3
|
Health Risk |
Pathogenic |
— |
| RS770330002 |
GJB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, 7 conditions |
| RS770330684 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS770330940 |
HBG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary persistence of fetal hemoglobin, Hereditary persistence of fetal hemoglobin |
| RS770331194 |
TNNC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy 13 |
| RS770334094 |
ABCB4
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 3, Progressive familial intrahepatic cholestasis type 3 |
| RS770334508 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS770334825 |
PCBD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency, Pterin-4 alpha-carbinolamine dehydratase 1 deficiency |
| RS770335133 |
BICD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures, Inborn genetic diseases |
| RS770335248 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS770335539 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS770335717 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Primary familial hypertrophic cardiomyopathy |
| RS770336099 |
POLR2C
|
Health Risk |
Likely pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS770336804 |
PDZD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing loss, autosomal recessive 57 |
| RS770336845 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS770336997 |
FBXO11
|
Health Risk |
Likely pathogenic |
FBXO11-related disorder, FBXO11-related disorder |
| RS770338663 |
KCNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 32 |
| RS770339001 |
SAMD9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS770339409 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Basal laminar drusen, Age related macular degeneration 4 |
| RS770339628 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS770339741 |
NDUFS6
|
Health Risk |
Pathogenic |
— |
| RS770339774 |
IMPG2
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS770339981 |
SPG7
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic ataxia, Hereditary spastic paraplegia 7 |
| RS770340227 |
SLC7A9
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS770340871 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
COL11A2-related disorder, COL11A2-related disorder |
| RS770341402 |
MFRP
|
Health Risk |
Pathogenic |
Isolated microphthalmia 5, Isolated microphthalmia 5 |
| RS770341565 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS770341883 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS770343200 |
HSD17B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS770344400 |
RPL3L
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, dilated |
| RS770344860 |
PNKP
|
Health Risk |
Likely pathogenic |
Microcephaly, seizures |
| RS770345026 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, normal intelligence and immunodeficiency |
| RS770346178 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial meningioma |
| RS770347484 |
AKT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 2 diabetes mellitus, Hypoinsulinemic hypoglycemia and body hemihypertrophy |
| RS770347536 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS770349910 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS770350755 |
ARID1B
|
Health Risk |
Likely pathogenic |
— |
| RS770350986 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS770352358 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatemic rickets, autosomal recessive |
| RS770352403 |
TGFBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome 2 |
| RS770352640 |
KCNJ13
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 16, Leber congenital amaurosis 16 |
| RS770352704 |
EXT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chondrosarcoma, Ovarian cancer |
| RS770353140 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS770354010 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS77035409 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS770355472 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS770355511 |
TUBG1
|
Health Risk |
Likely pathogenic |
Lissencephaly, Lissencephaly |
| RS770355592 |
OBSCN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS770356071 |
LCAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Fish-eye disease |
| RS770356158 |
EYA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Branchiootic syndrome 1, Otofaciocervical syndrome 1 |
| RS770356174 |
BCL11A
|
Health Risk |
Pathogenic |
Dias-Logan syndrome, Dias-Logan syndrome |
| RS770356922 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Nemaline myopathy 2 |
| RS770357627 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS770358039 |
SNX27
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS770359368 |
CHRNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 2A, Congenital myasthenic syndrome 4C |
| RS770361045 |
TRAPPC11
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS770362721 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia type I, Citrullinemia |
| RS770362811 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS770363653 |
TBC1D24
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 65, Developmental and epileptic encephalopathy |
| RS770364064 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Autosomal recessive Alport syndrome |
| RS770365711 |
POLR3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism, Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism |
| RS770366755 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 4A, Autosomal dominant nonsyndromic hearing loss 4A |
| RS770367814 |
C7
|
Health Risk |
Pathogenic/Likely pathogenic |
Complement component 7 deficiency, Complement component 7 deficiency |
| RS770368215 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS770368390 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS770368435 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome 2, Cardiovascular phenotype |
| RS770368608 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS770368711 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS770368733 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS770369582 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS770369588 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS770369940 |
EDAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type |
| RS770370694 |
SLC12A6
|
Health Risk |
Conflicting classifications of pathogenicity |
Agenesis of the corpus callosum with peripheral neuropathy, Agenesis of the corpus callosum with peripheral neuropathy |
| RS770372103 |
ADGRE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS770372463 |
DNAH8
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS770372675 |
MYL4
|
Health Risk |
Likely pathogenic |
Atrial fibrillation, familial |
| RS770373926 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Aortic aneurysm |
| RS770374058 |
TSFM
|
Health Risk |
Pathogenic |
— |
| RS770374710 |
MAGEL2
|
Health Risk |
Pathogenic |
Schaaf-Yang syndrome, Inborn genetic diseases |
| RS770374782 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS770374931 |
SLC19A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Megaloblastic anemia, thiamine-responsive |
| RS770375565 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS770375846 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Maturity-onset diabetes of the young |
| RS770377023 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS770377142 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS770377239 |
KBTBD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 6, Inborn genetic diseases |
| RS770379536 |
CYP21A2
|
Health Risk |
Likely pathogenic |
— |
| RS770380556 |
TRPM1
|
Health Risk |
Pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness |
| RS770381040 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated focal cortical dysplasia type II, Tuberous sclerosis 1 |
| RS770382841 |
QRICH2
|
Health Risk |
Pathogenic |
Spermatogenic failure 35, Spermatogenic failure 35 |
| RS770383273 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |